GLECAPREVIR/PIBRENTASVIR USE IN CHRONIC HEPATITIS C: EFFECTIVENESS AND SAFETY (submitted in 2019)
5PSQ-032
SUCCESSFUL TREATMENT OF CHRONIC HEPATITIS C INFECTION WITH CRUSHED SOFOSBUVIR/VELPATASVIR (submitted in 2019)
5PSQ-031
CLINICAL AND ECONOMIC IMPACT AFTER BREAKING THE SINGLE TABLET ABACAVIR/LAMIVUDINE/DOLUTEGRAVIR COMBO TREATMENT INTO TWO DRUG REGIMENES (submitted in 2019)
5PSQ-030
ADVERSE DRUG REACTIONS DUE TO INTERACTION WITH COBICISTAT OR RITONAVIR IN HIV POSITIVE PATIENTS: A CASE SERIES (submitted in 2019)
5PSQ-029
SAFE ADMINISTRATION OF SOFOSBUVIR/VELPATASVIR IN A PATIENT WITH PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (submitted in 2019)
5PSQ-027
OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY WORKING GROUP IN A HOSPITAL AT HOME UNIT: THE ESSENTIAL ROLE OF PHARMACISTS (submitted in 2019)
5PSQ-026
IMPACT OF THE EARLY SWITCHING FROM INTRAVENOUS TO ORAL ANTIBIOTICS IN A TERTIARY HOSPITAL (submitted in 2019)
5PSQ-025
PHARMACEUTICAL INTERVENTION FOR THE OPTIMISATION THE USE OF ANTIBIOTICS IN A TERTIARY HOSPITAL (submitted in 2019)
5PSQ-024
PHARMACOLOGIC INTERVENTION BY HOSPITAL PHARMCIST FOR LEUCOPENIA DUE TO TAZOBACTAM/PIPERACILLIN IN THE POSTPARTUM PERIOD: A CASE REPORT (submitted in 2019)
5PSQ-023
EFFECTIVENESS OF CEFTAZIDIME-AVIBACTAM IN INFECTIONS BY MULTIRESISTANT MICROORGANISMS. (submitted in 2019)
5PSQ-022
ANALYSIS OF INFECTIONS ASSOCIATED WITH CENTRAL VENOUS CATHETERS USED FOR ADMINISTRATION OF PARENTERAL NUTRITION IN A THIRD LEVEL HOSPITAL (submitted in 2019)
5PSQ-021
TRANSVAGINAL MESH IN PELVIC ORGAN PROLAPSES: 2017-2019 RETROSPECTIVE ANALYSIS (submitted in 2019)
5PSQ-020
ANALYSIS OF THE EFFECTIVENESS OF SECUKINUMAB AND IXEKIZUMAB IN THE TREATMENT OF MODERATE-SEVERE PSORIASIS (submitted in 2019)
5PSQ-019
EFFICACY OF SECUKINUMAB IN MODERATE-SEVERE PSORIASIS WITH A REDUCED TREATMENT REGIMEN (submitted in 2019)
5PSQ-018
ADALIMUMAB IN PALMOPLANTAR PUSTULOSIS (submitted in 2019)
